Rain Therapeutics Competitors and Similar CompaniesClear all
Rain Therapeutics's competitors and similar companies include Five Prime Therapeutics and ImmunoGen.
 Rain Therapeutics Rain Therapeutics is a biotechnology company focused on developing small molecule targeted therapeutics for cancer patients. |  Five Prime Therapeutics Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies. |  ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. | |
Founding Date | Founding Date 2017 | Founding Date 2001 | Founding Date 1981 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Newark, US HQ | Locations South San Francisco, US HQ | Locations Waltham, US HQ |
Employees | Employees 6343% increase | Employees 5141% decrease | Employees 277161% increase |
Valuation ($) | Valuation ($) 44 m | Valuation ($) N/A | Valuation ($) 8.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $13.2m (FY, 2020) | Revenue (est.) $108.8m (FY, 2022) |
Net income | Net income ($75.7m) (FY, 2022) | Net income ($84.3m) (FY, 2020) | Net income ($222.9m) (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 82.4m | Total funding raised $ 237.2m | Total funding raised $ 56m |
For sources of this data, please see the company profile
View Company Profiles
Five Prime Therapeutics
HQ
South San Francisco, US
Five Prime Therapeutics is a biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
View companyImmunoGen
HQ
Waltham, US
Employees
277
ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients.
View company